Veery Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$366K Buy
316
+8
+3% +$9.44K 0.1% 63
2026
Q2
$369K Sell
308
-2
-0.6% -$2.04K 0.1% 63
2026
Q1
$285K Sell
310
-1
-0.3% -$1.01K 0.09% 67
2025
Q4
$334K Buy
311
+1
+0.3% +$956 0.1% 62
2025
Q3
$237K Hold
310
– – 0.07% 80
2025
Q2
$242K Sell
310
-8
-3% -$6.22K 0.08% 77
2025
Q1
$263K Sell
318
-10
-3% -$8.32K 0.1% 66
2024
Q4
$253K Buy
328
+5
+2% +$4.14K 0.1% 68
2024
Q3
$286K Sell
323
-13
-4% -$11.7K 0.11% 67
2024
Q2
$304K Sell
336
-2
-0.6% -$1.6K 0.12% 71
2024
Q1
$263K Sell
338
-15
-4% -$10.7K 0.11% 79
2023
Q4
$206K Buy
+353
New +$206K 0.09% 86

Other funds holding LLY

Veery Capital's LLY Position: Q3 2026 in Review

Veery Capital increased its Eli Lilly (LLY) stake by 2.6% in Q3 2026, buying an estimated $9.44K and bringing the position to 316 shares worth $366K. The position accounts for 0.1% of the portfolio, ranked #63.

Veery Capital first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $369K in Q2 2026. 1,357 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Veery Capital held 316 shares of Eli Lilly worth $366K as of Q3 2026.
  • Veery Capital bought 8 Eli Lilly shares in Q3 2026, an estimated $9.44K.
  • Eli Lilly made up 0.1% of Veery Capital's portfolio in Q3 2026, its #63 holding.
  • Veery Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • Veery Capital's Eli Lilly position peaked at $369K in Q2 2026.
  • 1,357 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Veery Capital's 13F filing for Q3 2026, filed 7 Oct 2026.